• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Emergency

Decrease in admissions, testing of patients with brief resolved unexplained events

byStephanie Harlow, MDandCordelia Ross
September 5, 2019
in Emergency, Pediatrics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. After the 2016 change in the American Academy of Pediatrics’ (AAP) guidelines for brief resolved unexplained events (BRUEs), both rates of admission and of diagnostic testing for infants who presented to the emergency room with BRUEs decreased significantly from 2015 to 2017.

2. Despite this downtrend in admissions and diagnostic testing, revisits after initial presentation for BRUEs did not increase after the guideline changes and, rather, decreased slightly for infants less than 60 days old.

Evidence Rating Level: 2 (Good)    

Study Rundown: In 2016, the AAP renamed the previously-termed apparent life-threatening event (ALTE), instead referring to these episodes as BRUEs. In addition to renaming the events, the AAP also redefined the entity and changed management guidelines to include risk stratification and management recommendations for low-risk patients. Authors of this study sought to determine whether or not rates of admissions and diagnostic testing (such as MRIs, chest radiographs, electrocardiograms, and cerebral spinal fluid testing, among other things) decreased after the changes in these guidelines. Results from this retrospective cohort study suggested that rates of both admissions and diagnostic testing decreased, with admission rates being particularly low in infants greater than 2 months of age. Despite decreased rates of admissions and diagnostic testing, rates of revisits after initial presentation for BRUE did not increase after implementation of the new guidelines. Further study is required to determine whether or not outcomes changed following the guideline changes for this population of patients. Still, the overall trend away from admission and diagnostic testing without an increase in revisit rates indicates that the new guidelines have given providers both a safe and more cost-effective means of managing patients presenting with BRUE.

Click here to read the original article, published today in Pediatrics

Relevant Reading: Brief Resolved Unexplained Events (Formerly Apparent Life-Threatening Events) and Evaluation of Lower-Risk Infants

In-Depth [retrospective cohort]: In this study, researchers initially identified 16 556 infants across 26 states and the District of Columbia with BRUE or ALTE; they ultimately included 9501 infants in the final sample (54.5% white, 46.9-47.3% male). Dividing the cohort into infants age 0 to 60 days and 61 to 365 days, researchers reviewed admission rates in this population before and after implementation of the new guidelines, in 2015 and 2017, respectively. Using billing codes, researchers reviewed whether the following tests (among others) were completed during hospitalization: electrocardiogram, electroencephalogram, cerebral spinal fluid testing, computed tomography (CT) imaging, MRI of the brain, chest radiograph, abdominal ultrasound, blood glucose, electrolyte testing, and testing for inborn errors of metabolism. Researchers also sought to determine whether revisit rates decreased before and after implementation of the guideline. Ultimately, researchers found that admission rates decreased for both groups, with an even more significant decrease for infants 61 to 365 days (18.0%, 95% CI 15.3% to 20.7%) than for infants age 0 to 60 days (5.7%, 95% CI 3.8 to 7.5%). Diagnostic testing also decreased for both groups, with chest radiograph rates decreasing most significantly for both infants 0 to 60 days (9.8%, 95% CI 7.2 to 12.5%) and 61 to 365 days (11.5%, 95% CI 8.3 to 14.6%). Revisit rates showed no significant increase or decrease for either group (0-60 days: -1.0%, 95% CI -3.1 to 1.0%; 61-365 days: 2.3%, 95% CI -0.2 to 4.8%).

RELATED REPORTS

Lumbar puncture rates appropriately decline in children with simple febrile seizures

New guidelines define brief resolved unexplained events

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: American Academy of Pediatrics (AAP)apparent life-threatening event (ALTE)brief resolved unexplained event (BRUE)pediatric emergency
Previous Post

Quick Take: Association of Childhood-Onset Inflammatory Bowel Disease With Risk of Psychiatric Disorders and Suicide Attempt

Next Post

Quick Take: Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis

RelatedReports

Social networks play key roles in parental vaccination decisions
Infectious Disease

Lumbar puncture rates appropriately decline in children with simple febrile seizures

October 21, 2021
Increasing C-section room temperature linked to reduced neonatal, maternal hypothermia
Pediatrics

New guidelines define brief resolved unexplained events

April 25, 2016
Next Post
Brain lesions on MRI linked with subsequent increased stroke risk

Quick Take: Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis

Pre-exposure prophylaxis (PrEP) effective in preventing HIV infection in high-risk gay men

The NAMSAL ANRS 12313 trial: HIV viral suppression similar for dolutegravir and low-dose efavirenz treatment

Quick Take: Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm

The RELAX-AHF-2 trial: serelaxin provides no mortality benefit in acute heart failure patients

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Exhaled volatile organic compounds predict bronchopulmonary dysplasia in preterm infants
  • Wellness Check: Mental Health
  • SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options